Serum Institute of India CEO Adar Poonawalla on Tuesday said exports of its vaccine, Covishield, which became one of the first Covid-19 vaccines in India to get restricted emergency-use approval, are permitted to all countries. Earlier it was reported that Pune’s SII got the approval on the condition that it will not export its shots as of now.
The Associated Press reported that Poonawalla said his company has been barred from selling vaccines on private market.
Poonawalla also said a joint public statement clearing up “any recent miscommunication with regards to Bharat Biotech will be made”.
Serum Institute of India is world’s largest vaccine maker by the number of doses produced in a year. As it tied up with Astrazeneca and Oxford University to conduct trials in India and to produce the vaccines in India, several south Asian countries have shown interest in Covaxin. In November, an MoU was signed between the Bangladesh health ministry, Serum Institute and Bangladesh’s Beximco Pharmeceuticals according to which SII would provide 3 crore doses to Bangladesh.
Source: Read Full Article